Novel therapeutic targets in liver pathology: From basic science to clinical translation

Ralf Weiskirchen

doi:10.1002/jcb.30339

Novel therapeutic targets in liver pathology: From basic science to clinical translation — Ralf Weiskirchen (2022) | RDL Network

Back

Home
Publications
Novel therapeutic targets in liver pathology: From basic science to clinical translation

Shared by

Ralf Weiskirchen

Novel therapeutic targets in liver pathology: From basic science to clinical translation

Editorial Material 2022 en

Authors

RW
Ralf Weiskirchen

Abstract

Related publications

Article2020

The hepatic lipidome: From basic science to clinical translation

Marit ten Hove, L. V. Pater, Gert Storm, Sabine Weiskirchen, Ralf Weiskirchen, Twan Lammers, Ruchi Bansal

Article2025

No benefit from daratumumab, bortezomib and dexamethasone (D‐Vd) in real‐world patients with functional high‐risk multiple myeloma: A report from the Myeloma and Related Diseases Registry

1 min read

The data that support the findings of this study are openly available in Pubmed at https://pubmed.ncbi.nlm.nih.gov.

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1002/jcb.30339
Year: 2022
Published: —
Language: en

Editorial Material Details

Volume: 123
Issue: 10
Link Of The Paper: https://doi.org/10.1002/jcb.30339

Timeline

Created:June 19, 2026

Sueh‐li Lim, Cameron Wellard, Rajeev Rajagopal, Simon J. Harrison, Amit Khot, Hang Quach, P. Joy Ho, Elizabeth S. Moore, Erica M. Wood, Andrew Spencer

Letter2024

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria—authors’ response

Sompob Saralamba, J. A. Simpson, Sir Nicholas White

Journal of Antimicrobial Chemotherapy

Article2015

Propagation of Pathology through Brain Networks in Neurodegenerative Diseases: From Molecules to Clinical Phenotypes

Federica Agosta, Marina Weiler, Massimo Filippi

Preprint2020

Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol

Manoj M. Lalu, Joshua Montroy, C. Glenn Begley, Tania Bubela, Victoria Hunniford, David Ripsman, Neil Wesch, Jonathan Kimmelman, Malcolm Macleod, David Moher, Alvin Tieu, Lindsey Sikora, Dean Fergusson